Dose Attenuated Chemotherapy in Compromised Patients With Lung Cancer

Clinical trial NCT05800587 · RECRUITING

Trial details

NCT number: NCT05800587
Sponsor: Fox Chase Cancer Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Cancer Small-cell Lung Cancer Non Small Cell Lung Cancer

Start date: 2023-02-22
Primary completion: 2028-08-01
Enrollment: 280

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.